Share this article
Share this article
BOSTON, May 5, 2021 /PRNewswire/ Patrick J. Haraden has joined Lockton as President of its Boston operations. In his new role, Haraden will lead a team of property and casualty insurance and employee benefits experts who serve commercial clients nationally and globally.
Patrick J. Haraden
According to Tim Ryan, Chief Operating Officer of Lockton Northeast, Adding Pat to our team is evidence of our commitment to growth in New England. He has built a reputation as a dynamic leader in the industry, and we have every confidence in his ability to propel us forward in this important market through strong relationships with our clients and community. As we welcome Pat to his new role, we also express our appreciation for Chip Manozzi, who previously held this position and was instrumental in helping Lockton gain a foothold in Boston. Chip is stepping back from his leadership role to focus solely on serving his clients.
Detecting Rare Blood Clots Was A Win, But US Vaccine Safety System Still Has Gaps
The quick detection of an ultra-rare blood clotting reaction in some covid-19 vaccine recipients showed the power of a federal warning system for vaccine safety issues, but experts worry that blind spots in the program could hamper detection of other unexpected side effects.
Please share this article - Go to very top of page, right hand side, for social media buttons.
Before the pandemic began, the Food and Drug Administration had scaled back a program it used successfully to track adverse events during and after the 2009 H1N1 influenza pandemic, and the agency is still ramping up its replacement, said Dr. Robert Chen, scientific director of the Brighton Collaboration, a nonprofit global vaccine safety network.
Share this article
Share this article
WALTHAM, Mass., May 3, 2021 /PRNewswire/ On April 1, the New England Health Exchange Network (NEHEN) and the Massachusetts Health Data Consortium (MHDC) merged their organizations. The combined organization, retaining MHDC s name, will provide the health data community – clinicians, health care facilities, health plans, government, and consumers – with a range of community-governed data collaborations and services. These collaborations and services prepare MHDC s members to succeed in an interoperable future by providing the standards, tools, and insights that reduce unnecessary investment in redundant technologies and enable MHDC members to meet and exceed Federal and State regulations.
With its members, MHDC is developing a modern specification for API-based exchange of standardized clinical and administrative data, a prototype of automated prior authorization built on open industry standards, and a cloud-based service to enable provi
Government Executive
X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
Do Not Sell My Personal Information
When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you
U.S. Vaccine Safety System Still Has Gaps
By JoNel Aleccia, Kaiser Health News
Monday, May 03, 2021 (Kaiser News) The quick detection of an ultra-rare blood clotting reaction in some covid-19 vaccine recipients showed the power of a federal warning system for vaccine safety issues, but experts worry that blind spots in the program could hamper detection of other unexpected side effects.
Before the pandemic began, the Food and Drug Administration had scaled back a program it used successfully to track adverse events during and after the 2009 H1N1 influenza pandemic, and the agency is still ramping up its replacement, said Dr. Robert Chen, scientific director of the Brighton Collaboration, a nonprofit global vaccine safety network.